REG - Eden Research plc - 3LOGY Label Extension in Italy

Eden ResearchAnnouncement

Today 07:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20251120:nRST2675Ia&default-theme=true

RNS Number : 2675I  Eden Research plc  20 November 2025

20 November 2025

 

 

Eden Research Plc

("Eden" or "Company")

 

3LOGY Label Extension in Italy

 

3LOGY® has been approved in Italy for use across an additional range of new
crops and a number of new disease targets.

 

Eden Research plc (AIM: EDEN), a leader in sustainable biopesticide and
biocontrol technologies, is pleased to announce that 3LOGY (predominantly
known as Mevalone® outside of Italy) has been granted approval by the Italian
authorities for use on numerous new crops in order to control Botrytis and a
range of new diseases, including powdery mildew and Sclerotinia.

 

The label for 3LOGY has been expanded over time from a specialised fungicide
for grey mould (Botrytis cinerea) in grapes to a broad-spectrum fungicide for
multiple horticultural crops following its first label extension in Italy
in 2022. Now a leading biofungicide in the Italian market, 3LOGY has efficacy
on crops that require the highest quality standards, including leafy
vegetables, table grapes, and kiwis.

 

The new crops approved for 3LOGY include legumes (such as peas, lentils, and
chickpeas) as well as other crops such as avocado, carrot, radish, celery and
asparagus. This new approval extends the list of vegetables already
approved for 3LOGY, making it one of the most versatile tools for all
vegetable growers in Italy. Together, the new label extensions grow the
addressable market in Italy by more than twenty thousand hectares and provide
3LOGY with the opportunity to play a key role in the sustainable cultivation
of these high-value crops.

 

Sean Smith, CEO of Eden Research, commented:

 

"Eden's commercial partner, Sipcam Italia, has secured a further label
extension for 3LOGY in Italy.  Beyond the enlarged addressable market in
Italy, 3LOGY offers additional value for growers simply due to the extensive
list of crops on which it can now be used. This versatility allows farmers to
use it as a reference fungicide across cultivated open fields and in
greenhouses for certain crops.

 

This label extension reflects Eden's ongoing strategy to grow its core
business through the addition of not only new products, but also through the
expansion of regulatory authorisations for existing products that have
substantial additional potential beyond simple territorial expansions."

 

Stefano Ciannamea, Product Manager at Sipcam Italia, commented:

 

"This label extension enhances our competitive position within the fungicide
segment. Sipcam Italia and 3LOGY are now considered top-of-mind products for
Italian growers in a market with limited options. Although the potential sales
gains are difficult to quantify, we are positioning 3LOGY as the most reliable
solution for farmers."

 

 

 

 

For further information contact:

 

 Eden Research plc                                                       www.edenresearch.com (http://www.edenresearch.com/)
 Sean Smith                                                              01285 359 555

Alex Abrey

 Cavendish Capital Markets Limited (Nominated advisor and joint broker)
 Giles Balleny / George Lawson (Corporate Finance)                       020 7220 0500

 Harriet Ward (Corporate Broking)

Michael Johnson (Sales)

 Oberon Capital (Joint Broker)                                           020 3179 5300
 Nick Lovering

 Mike Seabrook

 Adam Pollock

 Hawthorn Advisors (Financial PR)
 Victoria Ainsworth                                                      eden@hawthornadvisors.com (mailto:eden@hawthornadvisors.com)

 

Notes to Editors:

 

Eden Research is the only UK-listed company focused on biopesticides for
sustainable agriculture. It develops and supplies innovative biopesticide
products and natural microencapsulation technologies to the global crop
protection, animal health and consumer products industries.

 

Eden's products are formulated with terpene active ingredients, based on
natural plant defence metabolites. To date, they have been primarily used on
high-value fruits and vegetables, improving crop yields and marketability,
with equal or better performance when compared with conventional pesticides.
Eden has three products currently on the market:

 

Based on plant-derived active ingredients, Mevalone® is a foliar
biofungicide which initially targets a key disease affecting grapes and other
high-value fruit and vegetable crops.  It is a useful tool in crop defence
programmes and is aligned with the requirements of integrated pest management
programmes. It is approved for sale in a number of key countries whilst Eden
and its partners pursue regulatory clearance in new territories thereby
growing Eden's addressable market globally.

 

Cedroz™( )is a bionematicide that targets free living nematodes which are
parasitic worms that affect a wide range of high-value fruit and vegetable
crops globally.  Cedroz is registered for sale on two continents and Eden's
commercial collaborator, Eastman Chemical, is pursuing registration and
commercialisation of this important new product in numerous countries
globally.

 

Eden's seed treatment product, EcovelexÔ was developed to safely tackle
crop destruction caused by birds - a major cause of losses in maize and other
crops. Ecovelex works by creating an unpleasant taste or odour that repels
birds, leaving the seeds safely intact and the birds unaffected and free to
find alternative food sources. The product is based on Eden's plant-derived
chemistry, registered in the EU, U.S. and elsewhere, and formulated using
Eden's Sustaine® microencapsulation system.

 

Eden's Sustaine(®)( )encapsulation technology is used to harness the
biocidal efficacy of naturally occurring chemicals produced by plants
(terpenes) and can also be used with both natural and synthetic compounds to
enhance their performance and ease-of-use. Sustaine microcapsules are
naturally-derived, plastic-free, biodegradable micro-spheres derived from
yeast. It is one of the only viable, proven and immediately registerable
solutions to the microplastics problem in formulations requiring
encapsulation.

 

Eden was admitted to trading on AIM on 11 May 2012 and trades under the
symbol EDEN. It was awarded the London Stock Exchange Green Economy
Mark in January 2021, which recognises London-listed companies that derive
over 50% of their total annual revenue from products and services that
contribute to the global green economy. Eden derives 100% of its total annual
revenues from sustainable products and services.

 

For more information about Eden, please visit:  www.edenresearch.com
(http://www.edenresearch.com/) .

 

Follow Eden on LinkedIn (https://www.linkedin.com/company/eden-research-plc/)
, Twitter (https://twitter.com/edenresearch)  and YouTube
(https://www.youtube.com/@edenresearch580) .

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  REAFZMMMZLZGKZZ



            Copyright 2019 Regulatory News Service, all rights reserved